Skip to the page

Data / Form D filings / Capra Biosciences, Inc.

Capra Biosciences, Inc.: Form D filings

Capra Biosciences, Inc., a technology company in Manassas, VA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on October 1, 2024, reports $500,000 sold of a $1.5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11100 ENDEAVOR CT UNIT 149, Manassas, VA, 20109
Phone
(202) 709-4184
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1902373

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 1, 2024New notice$1,500,000$500,000$1,000,0001Sep 16, 2024sec.gov
Dec 12, 2023New notice$5,000,000$3,400,000$1,600,0009Nov 28, 2023sec.gov
Jan 4, 2022New notice$1,500,000$50,000$1,450,0001Dec 20, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Andrew MagyarExecutive Officer, Director
Elizabeth OnderkoExecutive Officer, Director, Promoter
Pae WuDirector
Douglas CameronDirector
Danielle JosephDirector

Other technology companies in Virginia that filed recently

Every Form D from the week of Sep 30, 2024 · All recent filings in Virginia · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Capra Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.